Evidence map›Paper›PMID 38939992›Full record

ReviewCurrent pharmaceutical biotechnology2025

Biotechnological Breakthroughs in Resveratrol Synthesis and Health Advancements.

Ravi K Mittal, Gaurav Krishna, Raghav Mishra, Vikram Sharma

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pharmaceutical biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ravi K MittalGalgotias College of Pharmacy, Greater Noida, Uttar Pradesh, 201310, India.ORCID 0000-0001-8234-2466
Gaurav KrishnaGLA University, Mathura-281406, Uttar Pradesh, India.ORCID 0000-0003-1398-9340
Raghav MishraGLA University, Mathura-281406, Uttar Pradesh, India.ORCID 0000-0001-5269-2860
Vikram SharmaGalgotias College of Pharmacy, Greater Noida, Uttar Pradesh, 201310, India.ORCID 0000-0002-8655-7752

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This academic review examines the latest biotechnology methods for resveratrol synthesis. We aim to study the health advantages of resveratrol consumption beyond synthesis and demonstrate its potential as a therapeutic agent. An extensive examination of the current state of literature was performed, employing a diverse range of scholarly databases with the purpose of collating pertinent information and conducting in-depth research on the subject matter. The main goal was to find and assess research on resveratrol's health effects and the latest biotechnology methods for synthesizing it. This review paper discusses resveratrol synthesis methods, including their efficacy and current advances. The findings highlight the significant potential of biotechnological methods in improving both the synthesis of resveratrol and its beneficial effects on health. Our comprehensive analysis substantiates the importance of biotechnological methodologies in synthesizing resveratrol. The literature review highlights resveratrol's therapeutic properties, which have been scientifically approved for the prevention and treatment of various ailments, such as cardiovascular disease, metabolic illnesses, cancer, aging, and immunomodulation.

Indexed as

BiotechnologyResveratrolAnimalsHumansNeoplasmsResveratrolbiotechnological synthesismetabolic engineeringmicrobial productionnutraceuticalspolyphenolsResveratroltherapeutic applications.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.